Brian Lian

(Dr. Brian Lian Ph.D.)

Currently holds positions in Seelos Therapeutics Inc and Viking Therapeutics Inc

Positions

Position Company Period
Director Seelos Therapeutics Inc Jan. 24, 2019 -
President, Chief Executive Officer, Director Viking Therapeutics Inc June 3, 2015 -
Interim Chairman of the Board, President, Chief Executive Officer Viking Therapeutics Inc Sept. 1, 2012 - June 3, 2015
Brian Lian's trades of Viking Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-01-06 2025-01-06
S Sale
19,000 -0.8%
43.32
USD 823,021 		19,000 -0.8% 43.32 USD 823,021
2025-01-06 2025-01-06
S Sale
175,490 -6.9%
42.68
USD 7,490,580 		175,490 -6.9% 42.68 USD 7,490,580
2024-09-20 2024-09-20
PS Planned sale
200 -0.0%
71.99
USD 14,397 		200 -0.0% 71.99 USD 14,397
2024-09-20 2024-09-20
PS Planned sale
119,874 -4.9%
71.15
USD 8,529,047 		119,874 -4.9% 71.15 USD 8,529,047
2024-09-20 2024-09-20
PS Planned sale
96,056 -3.8%
70.43
USD 6,765,109 		96,056 -3.8% 70.43 USD 6,765,109
2024-08-22 2024-08-21
PS Planned sale
1,000 -0.0%
69.90
USD 69,900 		1,000 -0.0% 69.90 USD 69,900
2024-08-19 2024-08-19
PS Planned sale
11,296 -0.5%
67.12
USD 758,194 		11,296 -0.5% 67.12 USD 758,194
2024-08-19 2024-08-19
PS Planned sale
31,442 -1.3%
66.37
USD 2,086,821 		31,442 -1.3% 66.37 USD 2,086,821
2024-08-19 2024-08-19
PS Planned sale
70,132 -2.8%
65.33
USD 4,581,492 		70,132 -2.8% 65.33 USD 4,581,492
2024-07-31 2024-07-30
S Sale
30,417 -1.3%
58.78
USD 1,787,911 		30,417 -1.3% 58.78 USD 1,787,911
2024-07-31 2024-07-30
S Sale
19,501 -0.8%
57.81
USD 1,127,353 		19,501 -0.8% 57.81 USD 1,127,353
2024-07-31 2024-07-30
S Sale
65,941 -2.7%
56.95
USD 3,755,340 		65,941 -2.7% 56.95 USD 3,755,340
2024-02-09 2024-02-09
PS Planned sale
45,000 -2.1%
29.90
USD 1,345,500 		45,000 -2.1% 29.90 USD 1,345,500
2024-02-08 2024-02-08
PS Planned sale
40,000 -1.8%
28.90
USD 1,156,000 		40,000 -1.8% 28.90 USD 1,156,000
2024-02-08 2024-02-08
PS Planned sale
40,000 -1.8%
27.45
USD 1,098,000 		40,000 -1.8% 27.45 USD 1,098,000
2024-02-08 2024-02-08
PS Planned sale
80,000 -3.4%
26.95
USD 2,156,000 		80,000 -3.4% 26.95 USD 2,156,000
2024-02-08 2024-02-08
PS Planned sale
60,000 -2.5%
25.95
USD 1,557,000 		60,000 -2.5% 25.95 USD 1,557,000
2024-02-08 2024-02-08
PS Planned sale
49,079 -2.1%
25.75
USD 1,263,784 		49,079 -2.1% 25.75 USD 1,263,784
2024-01-31 2024-01-31
PS Planned sale
45,000 -1.9%
24.95
USD 1,122,750 		45,000 -1.9% 24.95 USD 1,122,750
2024-01-31 2024-01-31
PS Planned sale
40,000 -1.7%
24.45
USD 978,000 		40,000 -1.7% 24.45 USD 978,000
2024-01-30 2024-01-30
PS Planned sale
35,000 -1.5%
23.95
USD 838,250 		35,000 -1.5% 23.95 USD 838,250
2023-05-01 2023-05-01
PS Planned sale
45,000 -2.0%
22.45
USD 1,010,250 		45,000 -2.0% 22.45 USD 1,010,250
2023-04-21 2023-04-19
PS Planned sale
35,000 -1.5%
21.45
USD 750,750 		35,000 -1.5% 21.45 USD 750,750
2023-04-18 2023-04-17
PS Planned sale
155,000 -6.4%
20.45
USD 3,169,766 		155,000 -6.4% 20.45 USD 3,169,766
2023-04-13 2023-04-13
PS Planned sale
79,336 -3.3%
18.45
USD 1,463,749 		79,336 -3.3% 18.45 USD 1,463,749
2023-04-03 2023-04-03
PS Planned sale
22,000 -1.0%
17.85
USD 392,700 		22,000 -1.0% 17.85 USD 392,700
2023-04-03 2023-03-31
PS Planned sale
67,970 -2.9%
17.45
USD 1,186,077 		67,970 -2.9% 17.45 USD 1,186,077
2023-04-03 2023-03-30
PS Planned sale
65,382 -2.8%
17.45
USD 1,140,916 		65,382 -2.8% 17.45 USD 1,140,916
2023-04-03 2023-03-30
PS Planned sale
88,000 -3.7%
16.95
USD 1,491,600 		88,000 -3.7% 16.95 USD 1,491,600
// ... existing code ... // ... rest of the file ...